DANBURY, Conn.--(BUSINESS WIRE)--IMS Health (NYSE:IMS) today announced that it has selected Cloudera Enterprise to support its Big Data Factory, a cloud-based platform that transforms data into intelligence for life sciences and healthcare clients as they navigate dynamic markets, drive operational excellence and demonstrate the value of medicines. The collaboration with Cloudera—a leader in enterprise analytics data management powered by Apache Hadoop and the latest open source technologies—will accelerate and enhance data acquisition, processing and warehousing in the factory.
“As IMS Health continues to innovate with Big Data, Cloudera will advance our efforts to build and provision breakthrough data processing and data warehousing solutions,” said Karl Guenault, chief information officer and vice president of Operations, IMS Health. “We’re excited to apply Hadoop and other open source technologies for integrating, processing and interpreting more extensive and granular data—helping our customers drive healthcare performance.”
The combined solution will support:
- Next-generation data processing. Cloudera’s latest open source technology platforms support machine learning—which uses cognitive systems to automate quality control, data bridging and modeling, and other repetitive tasks—to drive evidence-based decisions for clients. Using the Hadoop cluster technology, IMS Health can extract, store and analyze vast quantities of unstructured data for generating new, more comprehensive insights for customers.
- Accelerated time to insight. The IMS Health Big Data Factory will harness Hadoop’s parallel processing technology to streamline data acquisition and management, delivering powerful insights with higher efficiency.
- Scalable data management. The Hadoop distributed file system (HDFS) eliminates data transfer bottlenecks, storage capacity delays and time spent adding new servers to augment traditional data clusters—enabling IMS Health to improve the speed and scalability of Big Data management.
“The insight that IMS Health will gain through the platform can ultimately be measured in better patient outcomes, and Cloudera is thrilled to work with them on this endeavor,” said Shawn Dolley, Cloudera industry leader for Health and Life Sciences. “As the leading provider of open source Hadoop solutions, Cloudera and IMS Health are uniquely positioned to support the growing needs of healthcare organizations looking to optimize their data utilization and provide better care.”
Cloudera delivers the modern data management and analytics platform built on Apache Hadoop and the latest open source technologies. The world’s leading organizations trust Cloudera to help solve their most challenging business problems with Cloudera Enterprise, the fastest, easiest and most secure data platform available for the modern world. Our customers efficiently capture, store, process and analyze vast amounts of data, empowering them to use advanced analytics to drive business decisions quickly, flexibly and at lower cost than has been possible before. To ensure our customers are successful, we offer comprehensive support, training and professional services. Learn more at cloudera.com.
About IMS Health
IMS Health is a leading global information and technology services company providing clients in the healthcare industry with end-to-end solutions to measure and improve their performance. Our 7,000 services experts connect configurable SaaS applications to 15+ petabytes of complex healthcare data in the IMS One™ cloud platform, delivering unique insights into diseases, treatments, costs and outcomes. The company’s 15,000 employees blend global consistency and local market knowledge across 100 countries to help clients run their operations more efficiently. Customers include pharmaceutical, consumer health and medical device manufacturers and distributors, providers, payers, government agencies, policymakers, researchers and the financial community.
As a global leader in protecting individual patient privacy, IMS Health uses anonymous healthcare data to deliver critical, real-world disease and treatment insights. These insights help biotech and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders to identify unmet treatment needs and understand the effectiveness and value of pharmaceutical products in improving overall health outcomes. Additional information is available at www.imshealth.com.